Steinberg RL, O'Donnell MA, Packiam VT. Non-risk Adapted Sequential Intravesical Gemcitabine and Docetaxel for Non-muscle Invasive Bladder Cancer: The Time is Now. J Urol 2023 Mar 31:101097JU0000000000003438. doi: 10.1097/JU.0000000000003438.
PMID: 37000006